Can Beyond Meat's Pivot to Protein Drinks Change the Investment Thesis?

Beyond Meat (NASDAQ: BYND) has faced an uncertain aboriginal for immoderate time. As income of its plant-based nutrient products person plummeted, the banal has mislaid much than 99% of its worth arsenic consumers and investors alike mislaid assurance successful the company.

Now, Beyond Meat has attempted to pivot into the macromolecule portion market. Amid that move, the question for investors is whether that strategical pivot changes the concern thesis for Beyond Meat oregon simply delays an inevitable decline.

Will AI make the world's archetypal trillionaire? Our squad conscionable released a study connected the 1 little-known company, called an "Indispensable Monopoly" providing the captious exertion Nvidia and Intel some need. Continue »

Beyond Meat and macromolecule drinks

Beyond Meat began 2026 facing superior fiscal and concern challenges. In 2025, its nett gross of $275 cardinal had fallen 16% from year-ago levels arsenic some home and planetary customers showed little involvement successful its plant-based nutrient products.

Additionally, the 2025 operating losses of $333 cardinal much than doubled from 2024 levels arsenic the outgo of goods sold unsocial astir matched gross levels. The lone crushed it turned a $178 cardinal nett for the twelvemonth is that it received a $549 cardinal payment from its indebtedness restructuring.

It was nether these challenging conditions that the institution launched its Beyond Immerse enactment of macromolecule drinks successful January. According to Maximize Market Research, the $35 cardinal macromolecule portion marketplace should turn astatine a 9.4% compound yearly maturation complaint (CAGR) done 2032, presumably signaling an accidental successful this area.

Unfortunately for Beyond Meat, it has not proven that macromolecule drinks are the turnaround catalyst the banal needs. That volition beryllium difficult, arsenic it has to vie with firm titans successful the beverage and wellness industries. This includes PepsiCo's Muscle Milk, Coca-Cola's Fairlife, and drinks similar Ensure and Glucerna, some developed by Abbott Laboratories.

Moreover, Beyond Meat does not look intelligibly committed to this merchandise line. It rolled retired this merchandise for a "limited time" from its Beyond Test Kitchen, which is improbable to boost capitalist assurance successful the stock.

Furthermore, though it whitethorn beryllium premature to look for fiscal improvements, nary person yet appeared successful the company's fiscal results. In the archetypal 4th of 2026, nett gross of $58 cardinal fell 15% twelvemonth implicit year. Also, its nett losses person resumed, though the $28 cardinal nonaccomplishment improved from the $61 cardinal nonaccomplishment successful the year-ago 4th amid assertive cost-cutting.